{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:58Z","timestamp":1740107818812,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The post-dialysis plasma level of human atrial natriuretic peptide (hANP) reflects the fluid volume in patients on hemodialysis. The threshold hANP level is reportedly 100\u00a0pg\/mL; however, the clinical usefulness of the threshold hANP level for volume control has not been sufficiently studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a single-center, retrospective, observational study that included 156 hemodialysis patients without atrial fibrillation. First, we examined the usefulness of the threshold hANP level (100\u00a0pg\/mL) for predicting hypoxemia due to congestion in a short-term observational study from December 30, 2015 to January 5, 2016. Subsequently, we conducted a 5-year follow-up study wherein the outcomes were hospitalization due to acute heart failure (AHF), development of cardiovascular diseases (CVD), and all-cause death. Finally, we collected echocardiography data to investigate the relationship between cardiac function and hANP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our short-term observational study showed that patients with an hANP level\u2009\u2265\u2009100\u00a0pg\/mL developed hypoxemia due to congestion (odds ratio, 3.52; 95% confidence interval, 1.06\u201311.71; P\u2009=\u20090.040). At the 5-year follow-up, patients with an hANP level\u2009\u2265\u2009100\u00a0pg\/mL had significantly higher rates of hospitalization due to AHF, CVD, and all-cause death based on the log-rank test (P\u2009=\u20090.003, P\u2009=\u20090.019, P\u2009&lt;\u20090.001, respectively). Cardiac disfunctions were significantly associated with the high hANP level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The hANP level is indicative of both fluid volume and cardiac dysfunction. A threshold hANP level of 100\u00a0pg\/mL can serve as a predictive marker for AHF and a practical indicator for volume control.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10157-023-02333-1","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T18:02:51Z","timestamp":1679335371000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing fluid volume and determining outcomes of acute heart failure using plasma human atrial natriuretic peptide"],"prefix":"10.1007","volume":"27","author":[{"given":"Yuya","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-3764","authenticated-orcid":false,"given":"Tadashi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomichi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Kaseda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikatsu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"issue":"5","key":"2333_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.kint.2016.12.008","volume":"91","author":"MJ Dekker","year":"2017","unstructured":"Dekker MJ, Marcelli D, Canaud BJ, Carioni P, Wang Y, Grassmann A, et al. Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort. Kidney Int. 2017;91(5):1214\u201323. https:\/\/doi.org\/10.1016\/j.kint.2016.12.008.","journal-title":"Kidney Int"},{"issue":"8","key":"2333_CR2","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1681\/asn.2016121341","volume":"28","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28(8):2491\u20137. https:\/\/doi.org\/10.1681\/asn.2016121341.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2333_CR3","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1093\/ndt\/gfaa182","volume":"36","author":"C Loutradis","year":"2021","unstructured":"Loutradis C, Sarafidis PA, Ferro CJ, Zoccali C. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management. Nephrol Dial Transplant. 2021;36(12):2182\u201393. https:\/\/doi.org\/10.1093\/ndt\/gfaa182.","journal-title":"Nephrol Dial Transplant"},{"issue":"4727","key":"2333_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1126\/science.2932797","volume":"230","author":"AJ de Bold","year":"1985","unstructured":"de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230(4727):767\u201370. https:\/\/doi.org\/10.1126\/science.2932797.","journal-title":"Science"},{"issue":"11","key":"2333_CR5","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1161\/01.cir.93.11.1946","volume":"93","author":"RO Bonow","year":"1996","unstructured":"Bonow RO. New insights into the cardiac natriuretic peptides. Circulation. 1996;93(11):1946\u201350. https:\/\/doi.org\/10.1161\/01.cir.93.11.1946.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"2333_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ndt\/11.supp2.28","volume":"11","author":"G Wolfram","year":"1996","unstructured":"Wolfram G, Sitter T, Gottsmann M, Gerzer R, Schiffl H. Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP. Nephrol Dial Transplant. 1996;11(Suppl 2):28\u201330. https:\/\/doi.org\/10.1093\/ndt\/11.supp2.28.","journal-title":"Nephrol Dial Transplant"},{"key":"2333_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12882-015-0212-4","volume":"16","author":"M Sivalingam","year":"2015","unstructured":"Sivalingam M, Vilar E, Mathavakkannan S, Farrington K. The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients. BMC Nephrol. 2015;16:218. https:\/\/doi.org\/10.1186\/s12882-015-0212-4.","journal-title":"BMC Nephrol"},{"issue":"5","key":"2333_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1159\/000502232","volume":"44","author":"S Niizuma","year":"2019","unstructured":"Niizuma S, Iwanaga Y, Washio T, Ashida T, Harasawa S, Miyazaki S, et al. Clinical significance of increased cardiac troponin T in patients with chronic hemodialysis and cardiovascular disease: comparison to B-type natriuretic peptide and A-type natriuretic peptide increase. Kidney Blood Press Res. 2019;44(5):1050\u201362. https:\/\/doi.org\/10.1159\/000502232.","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"2333_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1681\/asn.V1271508","volume":"12","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001;12(7):1508\u201315. https:\/\/doi.org\/10.1681\/asn.V1271508.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2333_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000073442","volume":"21","author":"T Nakatani","year":"2003","unstructured":"Nakatani T, Naganuma T, Masuda C, Sugimura T, Uchida J, Takemoto Y, et al. The prognostic role of atrial natriuretic peptides in hemodialysis patients. Blood Purif. 2003;21(6):395\u2013400. https:\/\/doi.org\/10.1159\/000073442.","journal-title":"Blood Purif"},{"issue":"5","key":"2333_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1744-9987.2012.01088.x","volume":"16","author":"H Hirakata","year":"2012","unstructured":"Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, et al. Japanese Society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial. 2012;16(5):387\u2013435. https:\/\/doi.org\/10.1111\/j.1744-9987.2012.01088.x.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"2333_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1536\/ihj.28.53","volume":"28","author":"Y Hirata","year":"1987","unstructured":"Hirata Y, Nozaki A, Toda I, Murakawa Y, Sugimoto T, Matsuoka H, et al. Plasma concentration of atrial natriuretic polypeptide in patients with atrial tachycardia. Jpn Heart J. 1987;28(1):53\u201361. https:\/\/doi.org\/10.1536\/ihj.28.53.","journal-title":"Jpn Heart J"},{"issue":"7","key":"2333_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/ggi.13118","volume":"17","author":"Y Ouchi","year":"2017","unstructured":"Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K, et al. Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017;17(7):1045\u20137. https:\/\/doi.org\/10.1111\/ggi.13118.","journal-title":"Geriatr Gerontol Int"},{"issue":"27","key":"2333_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"Eur Heart J"},{"issue":"4","key":"2333_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29(4):277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011.","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"2333_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/ki.1995.132","volume":"47","author":"JD Harnett","year":"1995","unstructured":"Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995;47(3):884\u201390. https:\/\/doi.org\/10.1038\/ki.1995.132.","journal-title":"Kidney Int"},{"issue":"2","key":"2333_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1507\/endocrj.40.257","volume":"40","author":"T Takagi","year":"1993","unstructured":"Takagi T, Nishikawa M, Inada M. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure. Endocr J. 1993;40(2):257\u201361. https:\/\/doi.org\/10.1507\/endocrj.40.257.","journal-title":"Endocr J"},{"issue":"4","key":"2333_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ki.1987.244","volume":"32","author":"H Saxenhofer","year":"1987","unstructured":"Saxenhofer H, Gn\u00e4dinger MP, Weidmann P, Shaw S, Schohn D, Hess C, et al. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int. 1987;32(4):554\u201361. https:\/\/doi.org\/10.1038\/ki.1987.244.","journal-title":"Kidney Int"},{"issue":"5","key":"2333_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","volume":"159","author":"CM O'Connor","year":"2010","unstructured":"O\u2019Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010;159(5):841-9.e1. https:\/\/doi.org\/10.1016\/j.ahj.2010.02.023.","journal-title":"Am Heart J"},{"issue":"6a","key":"2333_CR20","doi-asserted-by":"publisher","first-page":"11g","DOI":"10.1016\/j.amjcard.2005.07.016","volume":"96","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005;96(6a):11g-g17. https:\/\/doi.org\/10.1016\/j.amjcard.2005.07.016.","journal-title":"Am J Cardiol"},{"issue":"6","key":"2333_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/sdi.12721","volume":"31","author":"Y Ohashi","year":"2018","unstructured":"Ohashi Y, Sakai K, Hase H, Joki N. Dry weight targeting: the art and science of conventional hemodialysis. Semin Dial. 2018;31(6):551\u20136. https:\/\/doi.org\/10.1111\/sdi.12721.","journal-title":"Semin Dial"},{"issue":"2","key":"2333_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(sici)1520-6300(1999)11:2<167::Aid-ajhb4>3.0.Co;2-g","volume":"11","author":"JP Clarys","year":"1999","unstructured":"Clarys JP, Martin AD, Marfell-Jones MJ, Janssens V, Caboor D, Drinkwater DT. Human body composition: a review of adult dissection data. Am J Hum Biol. 1999;11(2):167\u201374. https:\/\/doi.org\/10.1002\/(sici)1520-6300(1999)11:2%3c167::Aid-ajhb4%3e3.0.Co;2-g.","journal-title":"Am J Hum Biol"},{"issue":"8","key":"2333_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/jcu.23318","volume":"50","author":"AG Ovchinnikov","year":"2022","unstructured":"Ovchinnikov AG, Potekhina A, Belyavskiy E, Gvozdeva A, Ageev F. Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome. J Clin Ultrasound. 2022;50(8):1073\u201383. https:\/\/doi.org\/10.1002\/jcu.23318.","journal-title":"J Clin Ultrasound"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02333-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02333-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02333-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T10:13:11Z","timestamp":1684318391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02333-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2333"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02333-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number # 12000056) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}